Please login to the form below

Speakers Announced: Maintaining Market Access Continuity through a Global Pandemic Webinar

The global outbreak of coronavirus (COVID-19) and subsequent perception of public health risk creates challenges for international business continuity and market access planning.

In this expert led round table, we bring together key industry stakeholders to share perspectives on some of the implications and consider solutions for how to mitigate the impact on your business at this time of uncertainty.

Key topics will include:

  • Delays to market access planning
  • Market access consequences of sourcing and supply chain issues
  • Delays to day-to-day external engagements
  • Solutions to ensure market access function continuity

This round table brings together leading experts from the pharmaceutical industry, HTA bodies and public health experts to discuss consequences, threats and opportunities, and how to maintain continuity.

The webinar is relevant for market access, pricing, health economics, marketing, commercial and regulatory professionals.

Register your interest here: https://register.gotowebinar.com/register/6893959202322429964

The webinar will be moderated by Raf De Wilde, Senior Executive Advisor at Valid Insight, where he will be joined by expert panellists:

  • Dr. Mathias Flume, Head of Prescription Management at KVWL, Germany
  • Professor Fabrizio Gianfrate, Professor of Health Economics at Rome and Ferrara Universities. Ex-member of the Italian Government Drug Agency (AIFA) and HTA formulary committee and Director at the Ministry of Health
  • Scott Johnstone, CEO of the Scottish Lifesciences Association
  • Sue Caleo-Naeyaert, Senior Advisor Valid Insight, Former Global Head Government Affairs, Policy and Pharmaceconomics at Fresenius Kabi SwissBioSim
  • Professor Jean Paul Stahl, Professor of Infectious Diseases, University Hospital, Grenoble, France. Former President of the French Infectious Diseases Society
  • Edmund Pezalla, Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy at Aetna

Register your interest here: https://register.gotowebinar.com/register/6893959202322429964

17th March 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Valid Insight Queen’s Award presentation: recognising a market access company
Take a look at the very moment that one of the most esteemed business awards, the Queen’s Award for Enterprise in International Trade 2019, was presented to our team.
Valid Insight
Speakers Announced: Maintaining Market Access Continuity through a Global Pandemic Webinar
The global outbreak of coronavirus (COVID-19) and subsequent perception of public health risk creates challenges for international business continuity and market access planning.
Valid Insight
Webinar: Maintaining Market Access Continuity through a Global Pandemic
The global outbreak of coronavirus (COVID-19) and subsequent perception of public health risk creates challenges for international business continuity and market access planning.
Valid Insight
Valid Insight Supporting Initiatives To Support COVID-19 Travel Bans
The World Pharma Pricing Market Access & Evidence Congress
Valid Insight
Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines.
Valid Insight
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the evaluation of health and healthcare interventions.
Valid Insight